Today’s top gainers include the company Quest Diagnostics Inc. (NYSE:DGX) which is in the industry Medical Laboratories & Research, gaining 2.12% today. In the last week its performance is 3.37%, and 7.15% for the past quarter. Currently, Quest Diagnostics Inc., DGX has a target price of 82.89, so today’s gain of 2.12% is a significant step towards its target price. The GAP today is therefore 0.17%.
Quest Diagnostics Inc. (NYSE:DGX), has a market cap of 11768.38, and is based in USA. Insider ownership is at 0.20%, and institutional ownership is 96.80%.
At the current price of 84.86, it has a dividend yield of 1.89%, and its target price is 82.89. This is with a profit margin of 11.00%, and total debt/equity of 0.85. Quest Diagnostics Inc. (NYSE:DGX) has a P/E of 14.85, as well as a forward P/E of 15.57.
With a current EPS of 5.72, and a forecasted EPS growth for next year at 6.74%,Quest Diagnostics Inc. (NYSE:DGX) has had a EPS growth for the past five years at 4.10%. For the next five years EPS growth is projected to be 7.63%.
Performance for the year is 31.25%. Since its IPO date on 12/26/1996, the total performance to date is 21.22%.
Volume today for Quest Diagnostics Inc. (NYSE:DGX), is 1204300, while its average volume is 1196.33. Whilst the total gain today was 2.12%, it did have a day high of -2.29%.
Volatility for this week has been at 1.50%, and 1.58% for the month. The 52-week low for Quest Diagnostics Inc., DGX has been 44.44%, while the 52-week-high has reached -2.29%.
Looking at its return of investments, which is 12.30%, and its return on assets is 8.20%. Quest Diagnostics Inc. (NYSE:DGX) has an operating margin of 20.70%. With a sales growth of -1.00% quarter over quarter. Bearing in mind that Quest Diagnostics Inc., DGX is in the sector Healthcare, its long-term debt/equity is 0.85, and has a current ratio of 1.4 and 1.3 for quick ratio.
So what is the value of Quest Diagnostics Inc.? Well its PEG is 1.95, and the P/S is 1.57, along with a P/B of 2.62. Meanwhile it has a p/cash of 41.58.